"Cystic Fibrosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Descriptor ID |
D003550
|
| MeSH Number(s) |
C06.689.202 C08.381.187 C16.320.190 C16.614.213
|
| Concept/Terms |
Pancreatic Cystic Fibrosis- Pancreatic Cystic Fibrosis
- Cystic Fibrosis, Pancreatic
- Fibrocystic Disease of Pancreas
- Pancreas Fibrocystic Disease
- Pancreas Fibrocystic Diseases
- Cystic Fibrosis of Pancreas
|
Below are MeSH descriptors whose meaning is more general than "Cystic Fibrosis".
Below are MeSH descriptors whose meaning is more specific than "Cystic Fibrosis".
This graph shows the total number of publications written about "Cystic Fibrosis" by people in this website by year, and whether "Cystic Fibrosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 |
| 1997 | 3 | 1 | 4 |
| 1998 | 2 | 2 | 4 |
| 1999 | 7 | 1 | 8 |
| 2000 | 5 | 1 | 6 |
| 2001 | 2 | 1 | 3 |
| 2002 | 4 | 1 | 5 |
| 2003 | 2 | 2 | 4 |
| 2004 | 2 | 0 | 2 |
| 2005 | 0 | 2 | 2 |
| 2006 | 3 | 1 | 4 |
| 2007 | 3 | 3 | 6 |
| 2008 | 2 | 3 | 5 |
| 2009 | 4 | 0 | 4 |
| 2010 | 6 | 0 | 6 |
| 2011 | 7 | 0 | 7 |
| 2012 | 6 | 1 | 7 |
| 2013 | 7 | 0 | 7 |
| 2014 | 5 | 3 | 8 |
| 2015 | 5 | 0 | 5 |
| 2016 | 2 | 0 | 2 |
| 2017 | 7 | 3 | 10 |
| 2018 | 5 | 1 | 6 |
| 2019 | 7 | 2 | 9 |
| 2020 | 12 | 0 | 12 |
| 2021 | 13 | 0 | 13 |
| 2022 | 8 | 0 | 8 |
| 2023 | 10 | 0 | 10 |
| 2024 | 6 | 0 | 6 |
| 2025 | 4 | 0 | 4 |
| 2026 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cystic Fibrosis" by people in Profiles.
-
Profile of cystic fibrosis transmembrane conductance regulator (CFTR) gene variants across India and their variability in different geographic regions. Gene. 2026 Jan 15; 976:149870.
-
Gastrointestinal Burden in Patients With Pancreatic Insufficient Cystic Fibrosis Before and After Elexacaftor/Tezacaftor/Ivacaftor Use. Pancreas. 2025 Nov-Dec 01; 54(10):e858-e862.
-
SHIFTing goals in cystic fibrosis-managing extrapulmonary disease in the era of CFTR modulator therapy; Proceedings of the International Shaping Initiatives and Future Trends (SHIFT) Symposium. Pediatr Pulmonol. 2024 06; 59(6):1661-1676.
-
Optimizing sexual reproductive health of men and women with cystic fibrosis: A systematic review. J Cyst Fibros. 2024 07; 23(4):633-638.
-
Prospective study of quantitative liver MRI in cystic fibrosis: feasibility and comparison to PUSH cohort ultrasound. Pediatr Radiol. 2023 10; 53(11):2210-2220.
-
Application of organ dysfunction assessment scores following pediatric lung transplantation. Clin Transplant. 2023 03; 37(3):e14863.
-
Long-term follow-up and liver outcomes in children with cystic fibrosis and nodular liver on ultrasound in a multi-center study. J Cyst Fibros. 2023 03; 22(2):248-255.
-
Cystic fibrosis lung transplant recipients 10 years of age or younger: Predisposing factors for end-stage disease. Pediatr Pulmonol. 2022 06; 57(6):1513-1519.
-
Clinical outcomes in cystic fibrosis at 6 years of age with tricare insurance coverage. J Cyst Fibros. 2022 11; 21(6):984-987.
-
Intestinal Absorption of Lipids Using a Pancreatic Enzyme-Free Nutritional Supplement in Patients with Cystic Fibrosis: A Randomized, Double-Blind, Crossover Pilot Trial. Nutrients. 2022 Feb 05; 14(3).